TP53
Oncology
4 drugs in development·3 companies·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| eltanexor | Karyopharm Therapeutics Inc. (KPTI) |
Phase 1(2)
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| eli-008 | Elicio Therapeutics, Inc. (ELTX) |
Compare drugs
Frequently asked questions
How many drugs are in development for TP53?
BioSniper tracks 4 drugs in development for TP53 across 3 companies.
How many clinical trials target TP53?
There are 1 clinical trial targeting TP53 tracked by BioSniper.
Deep-dive into TP53
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis